scholarly journals Evaluation of the Absorbed Radiation Dose for Thyroid Gland in Chest Tumor Radiotherapy

Author(s):  
Y. Wang ◽  
L. He ◽  
M. Zheng ◽  
J. Wang ◽  
J. Xu ◽  
...  
Scientifica ◽  
2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Atif N. Khan ◽  
Waqas Shuaib ◽  
Boris Nikolic ◽  
Mohammad K. Khan ◽  
Jian Kang ◽  
...  

Aim. To determine absorbed radiation dose (ARD) in radiosensitive organs during prospective and full phase dose modulation using ECG-gated MDCTA scanner under 64- and 320-row detector modes.Methods. Female phantom was used to measure organ radiation dose. Five DP-3 radiation detectors were used to measure ARD to lungs, breast, and thyroid using the Aquilion ONE scanner in 64- and 320-row modes using both prospective and dose modulation in full phase acquisition. Five measurements were made using three tube voltages: 100, 120, and 135 kVp at 400 mA at heart rate (HR) of 60 and 75 bpm for each protocol. Mean acquisition was recorded in milligrays (mGy).Results. Mean ARD was less for 320-row versus 64-row mode for each imaging protocol. Prospective EKG-gated imaging protocol resulted in a statistically lower ARD using 320-row versus 64-row modes for midbreast (6.728 versus 19.687 mGy,P<0.001), lung (6.102 versus 21.841 mGy,P<0.001), and thyroid gland (0.208 versus 0.913 mGy;P<0.001). Retrospective imaging using 320- versus 64-row modes showed lower ARD for midbreast (10.839 versus 43.169 mGy,P<0.001), lung (8.848 versus 47.877 mGy,P<0.001), and thyroid gland (0.057 versus 2.091 mGy;P<0.001). ARD reduction was observed at lower kVp and heart rate.Conclusions. Dose reduction to radiosensitive organs is achieved using 320-row compared to 64-row modes for both prospective and retrospective gating, whereas 64-row mode is equivalent to the same model 64-row MDCT scanner.


1981 ◽  
Vol 20 (02) ◽  
pp. 72-75 ◽  
Author(s):  
R. Kocak ◽  
R.G. Herbert ◽  
C.R. Squire ◽  
T.M.D. Gimlette

Radioiodine in the thyroid gland after a therapy dose of 131I was measured serially in 7 patients without Carbimazole, and in 11 patients starting Carbimazole 60 mg daily fourteen days after the therapy dose. Effective half-life for radioiodine in the gland initially 5.53±1.08 days fell to 4.26±1.12 days (p < 0.01) during Carbimazole, and returned to 5.83±1.21 days (NS) after stopping the drug. The radiation dose to the thyroid from a given therapy dose of 131I followed by Carbimazole was calculated to be 97% of that without Carbimazole when the drug was started after 14 days, and 90% and 75% when the drug was started after 7 days and 1 day respectively.


2020 ◽  
Author(s):  
Nurul Fitriyah ◽  
Rahmatul Izza Nur Amalia ◽  
Bambang Haris Suhartono ◽  
Suryani Dyah Astuti

1996 ◽  
Vol 6 (4) ◽  
Author(s):  
K. Nakamura ◽  
T. Ishiguchi ◽  
H. Maekoshi ◽  
Y. Ando ◽  
M. Tsuzaka ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Kfier Kuba ◽  
Diana Wolfe ◽  
Alan H. Schoenfeld ◽  
Anna E. Bortnick

There is a gap in the literature regarding fetal radiation exposure from interventional cardiac procedures. With an increasingly large and complex cohort of pregnant cardiac patients, it is necessary to evaluate the safety of invasive cardiac procedures and interventions in this population. Here we present a case of a patient with multiple medical comorbidities and non-ST elevation myocardial infarction (NSTEMI) at 15 weeks’ gestation, managed with percutaneous coronary intervention (PCI). We were able to minimize the maternal and estimated fetal absorbed radiation dose to <1 milliGray (mGy), significantly less than the threshold dose for fetal adverse effects at this gestational age.


1988 ◽  
Vol 13 (11) ◽  
pp. 594-597 ◽  
Author(s):  
Peter H. Hasler ◽  
Klaus Seybold ◽  
Roger Y. Andres ◽  
Johannes T. Locher ◽  
P. August Schubiger

Sign in / Sign up

Export Citation Format

Share Document